Amitabh Gulati

Amitabh Gulati is a Clinical Assistant Professor of Anesthesiology at Weill Cornell Medical College, Cornell University, where he has held a faculty position since 2011. His clinical expertise centers on interventional pain management for oncology patients, with specialized focus on neuromodulation, intrathecal drug delivery, and ultrasound-guided procedures for cancer-related pain.

His educational background includes:

• Bachelor of Science (B.S.) from the University of Texas (1998)
• Doctor of Medicine (M.D.) from Baylor College of Medicine (2002)

Dr. Gulati's research program bridges anesthesiology and oncology through innovative interventional approaches. He has pioneered work in peripheral nerve stimulation for refractory cancer pain, developed consensus guidelines for neuromodulation training (PEAK initiative), and advanced techniques for managing bone metastases pain. His scholarship critically examines opioid-sparing strategies, including cannabinoids and novel neurostimulation systems, while addressing practical challenges in intrathecal therapy for palliative care. As a clinician-investigator, he emphasizes translating evidence into standardized protocols for complex pain scenarios in cancer survivors.

Analysis of his 2021-2023 publications reveals three dominant themes: 1) Optimization of neuromodulation devices (spinal cord/peripheral nerve stimulation) through international expert surveys and case series; 2) Standardization of intrathecal drug delivery practices via large-scale clinical surveys; 3) Development of multimodal, opioid-reduction frameworks for bone metastases pain using Delphi consensus methods. His work consistently targets the intersection of technological innovation and practical clinical implementation in oncology pain management.

Dr. Gulati actively shapes the field through high-impact publications in Regional Anesthesia and Pain Medicine, Neuromodulation, and Pain Medicine, with several articles exceeding 20 citations. His leadership in the American Society of Pain and Neuroscience (ASPN) guidelines demonstrates commitment to establishing evidence-based standards for cancer pain interventions.